$PRSI
PORTSMOUTH SQUARE INC Stock $prsi

$prsi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041164 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q2
Revenue	$10.23M	$11.09M	$9.400M
YoY Change	3.37%	-9.89%	-19.99%
Cost Of Revenue	$9.405M	$9.281M	$8.010M
YoY Change	7.78%	-0.27%	-1.05%
Gross Profit	$820.0K	$1.812M	$1.380M
YoY Change	-29.67%	-39.68%	-62.23%
Gross Profit Margin	8.02%	16.33%	14.68%
Selling, General & Admin	$434.0K	$320.0K	$470.0K
YoY Change	-16.05%	3.56%	97.48%
% of Gross Profit	52.93%	17.66%	34.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$842.0K	$821.0K	$760.0K
YoY Change	17.6%	50.37%	23.38%
% of Gross Profit	102.68%	45.31%	55.07%
Operating Expenses	-$9.839M	-$9.600M	$1.230M
YoY Change	6.45%	-0.16%	44.03%
Operating Profit	-$455.0K	$672.0K	$150.0K
YoY Change	-3350.0%	-67.5%	-94.64%
Interest Expense	-$2.067M	-$2.190M	-$2.080M
YoY Change	4.87%	7.04%	-13.84%
% of Operating Profit		-325.89%	-1386.67%
Other Income/Expense, Net	-$2.111M	-$2.231M	-$40.00K
YoY Change	2.88%	7.26%	-14.89%
Pretax Income	-$2.566M	-$1.559M	-$1.970M
YoY Change	25.91%	12891.67%	-681.12%
Income Tax		$1.000K	$8.840M
% Of Pretax Income
Net Earnings	-$2.566M	-$1.560M	-$10.82M
YoY Change	94.39%	17233.33%	440.73%
Net Earnings / Revenue	-25.1%	-14.06%	-115.11%
Basic Earnings Per Share	-$3.50	-$2.12
Diluted Earnings Per Share	-$3.50	-$2.12	-$14.82
COMMON SHARES
Basic Shares Outstanding	734.2K shares	734.2K shares	734.2K shares
Diluted Shares Outstanding	734.2K shares	734.2K shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.993M	$4.420M	$2.654M
YoY Change	159.62%	50.44%	-17.14%
Cash & Equivalents	$3.668M	$4.149M	$2.295M
Short-Term Investments	$325.0K	$271.0K	$359.0K
Other Short-Term Assets
YoY Change
Inventory			$27.00K
Prepaid Expenses
Receivables	$447.0K	$450.0K	$420.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.115M	$4.600M	$2.720M
YoY Change	163.78%	58.95%	-10.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$34.64M	$34.32M	$34.38M
YoY Change	6.09%	6.47%	10.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$325.0K	$270.0K	$360.0K
YoY Change	7.62%	-8.47%	-33.46%
Other Assets	$800.0K	$2.850M	$2.910M
YoY Change	-93.7%	-79.91%	-79.42%
Total Long-Term Assets	$36.74M	$38.17M	$38.38M
YoY Change	-22.56%	-19.18%	-17.92%
TOTAL ASSETS
Total Short-Term Assets	$4.115M	$4.600M	$2.720M
Total Long-Term Assets	$36.74M	$38.17M	$38.38M
Total Assets	$40.86M	$42.77M	$41.10M
YoY Change	-16.63%	-14.67%	-17.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.45M	$14.17M	$18.96M
YoY Change	65.18%	48.64%	286.31%
Accrued Expenses	$4.821M	$5.030M
YoY Change	46.53%	26.96%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$21.24M	$21.06M	$18.96M
YoY Change	37.61%	42.9%	286.31%
LONG-TERM LIABILITIES
Long-Term Debt	$127.4M	$126.9M	$125.8M
YoY Change	1.63%	0.86%	-0.7%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$127.4M	$126.9M	$125.8M
YoY Change	1.63%	0.86%	-0.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.24M	$21.06M	$18.96M
Total Long-Term Liabilities	$127.4M	$126.9M	$125.8M
Total Liabilities	$148.6M	$148.0M	$144.7M
YoY Change	5.58%	5.26%	3.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$109.9M	-$107.3M	-$105.7M
YoY Change	17.05%	15.94%	14.27%
Common Stock	$2.092M	$2.092M	$2.092M
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$107.8M	-$105.2M	-$103.6M
YoY Change
Total Liabilities & Shareholders Equity	$40.86M	$42.77M	$41.10M
YoY Change	-16.63%	-14.67%	-17.47%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$2.566M	-$1.560M	-$10.82M
YoY Change	94.39%	17233.33%	440.73%
Depreciation, Depletion And Amortization	$842.0K	$821.0K	$760.0K
YoY Change	17.6%	50.37%	23.38%
Cash From Operating Activities	-$1.913M	$1.332M	$1.200M
YoY Change	47.49%	-41.4%	-52.9%
INVESTING ACTIVITIES
Capital Expenditures	$1.159M	$755.0K	$1.740M
YoY Change	10.38%	-53.74%	-850.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$1.159M	-$755.0K	-$1.740M
YoY Change	10.38%	-53.74%	650.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	544.0K	$1.219M	1.030M
YoY Change	-198.91%	-299.18%	-297.32%
NET CHANGE
Cash From Operating Activities	-1.913M	$1.332M	1.200M
Cash From Investing Activities	-1.159M	-$755.0K	-1.740M
Cash From Financing Activities	544.0K	$1.219M	1.030M
Net Change In Cash	-2.528M	$1.796M	490.0K
YoY Change	-12.74%	6093.1%	-72.69%
FREE CASH FLOW
Cash From Operating Activities	-$1.913M	$1.332M	$1.200M
Capital Expenditures	$1.159M	$755.0K	$1.740M
Free Cash Flow	-$3.072M	$577.0K	-$540.0K
YoY Change	30.89%	-9.98%	-119.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000079661
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities		usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities		usd
CY2023Q3	PRSI	Increase Decrease In Due To Securities Broker IncreaseDecreaseInDueToSecuritiesBroker		usd
CY2022Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		usd
CY2023Q2	PRSI	Mortgage Interest Payable MortgageInterestPayable		usd
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	0-4057
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	PORTSMOUTH SQUARE, INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-1674111
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	1516 S. Bundy Dr.
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90025
CY2023Q3	dei	City Area Code CityAreaCode	(310)
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	889-2500
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	734187	shares
CY2023Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34315000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34381000	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	271000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	359000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4149000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2295000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	2853000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	2911000	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	453000	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	419000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	730000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	735000	usd
CY2023Q3	us-gaap	Assets Assets	42771000	usd
CY2023Q2	us-gaap	Assets Assets	41100000	usd
CY2023Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2813000	usd
CY2023Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2954000	usd
CY2023Q3	PRSI	Mortgage Notes Payable MortgageNotesPayable	106896000	usd
CY2023Q2	PRSI	Mortgage Notes Payable MortgageNotesPayable	107117000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	147966000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	144735000	usd
CY2023Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	734187	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	734187	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	734187	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	734187	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2092000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2092000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-107287000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-105727000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-105195000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-103635000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42771000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41100000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11093000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12310000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9281000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9306000	usd
CY2023Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	821000	usd
CY2022Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	627000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	319000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	309000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	10421000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	10242000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	672000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2068000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1606000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1632000	usd
CY2023Q3	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-88000	usd
CY2022Q3	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-10000	usd
CY2023Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3000	usd
CY2022Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	26000	usd
CY2023Q3	PRSI	Trading And Margin Interest Expense TradingAndMarginInterestExpense	38000	usd
CY2022Q3	PRSI	Trading And Margin Interest Expense TradingAndMarginInterestExpense	34000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2231000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2080000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1559000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1560000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-9000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.12
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	734187	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	734187	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	734187	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	734187	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-103635000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-103635000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1560000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-105195000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-105195000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-90432000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-90432000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-9000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-90441000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-90441000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1560000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-9000	usd
CY2023Q3	PRSI	Marketable Securities Unrealized Gain Loss Including Gain Loss On Common Stock MarketableSecuritiesUnrealizedGainLossIncludingGainLossOnCommonStock	-88000	usd
CY2022Q3	PRSI	Marketable Securities Unrealized Gain Loss Including Gain Loss On Common Stock MarketableSecuritiesUnrealizedGainLossIncludingGainLossOnCommonStock	90000	usd
CY2023Q3	PRSI	Amortization Of Other Notes Payable AmortizationOfOtherNotesPayable	141000	usd
CY2022Q3	PRSI	Amortization Of Other Notes Payable AmortizationOfOtherNotesPayable	142000	usd
CY2022Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	821000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	627000	usd
CY2023Q3	PRSI	Amortization Of Loan Costs AmortizationOfLoanCosts	60000	usd
CY2022Q3	PRSI	Amortization Of Loan Costs AmortizationOfLoanCosts	61000	usd
CY2022Q3	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-336000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-126000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-5000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-339000	usd
CY2023Q3	PRSI	Increase Decrease In Accounts Payable And Other Liabilities IncreaseDecreaseInAccountsPayableAndOtherLiabilities	-898000	usd
CY2022Q3	PRSI	Increase Decrease In Accounts Payable And Other Liabilities IncreaseDecreaseInAccountsPayableAndOtherLiabilities	851000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	2067000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	924000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	307000	usd
CY2022Q3	PRSI	Increase Decrease In Due To Securities Broker IncreaseDecreaseInDueToSecuritiesBroker	-130000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1332000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2273000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	755000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1632000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-755000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1632000	usd
CY2023Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1500000	usd
CY2023Q3	PRSI	Payment Of Mortgage And Finance Leases Net PaymentOfMortgageAndFinanceLeasesNet	281000	usd
CY2022Q3	PRSI	Payment Of Mortgage And Finance Leases Net PaymentOfMortgageAndFinanceLeasesNet	612000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1219000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-612000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1796000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5206000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8888000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7002000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8917000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	1606000	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	2061000	usd
CY2017Q1	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	automatically renews for successive one (1) year periods, not to exceed five years in the aggregate, subject to certain conditions.
CY2017Q1	PRSI	Percentage Of Management Fee Payable PercentageOfManagementFeePayable	0.0170	pure
CY2023Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3bjdqg70rod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zlPPIinHl8zj">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain line items on the statement of cash flows for the three months ended September 30, 2022, have been reclassified to conform to the current period presentation. Net cash provided by (used in) operating, investing, and financing activities did not change as a result of this reclassification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
CY2023Q3	PRSI	Mortgage Notes Payable MortgageNotesPayable	106896000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-107287000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1332000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4149000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2295000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	2853000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	2911000	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	271000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	359000	usd
CY2023Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1500000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	2911000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7002000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5206000	usd
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2023Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segments
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11093000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12310000	usd
CY2023Q3	PRSI	Contract Assets Other Than Trade And Other Receivables ContractAssetsOtherThanTradeAndOtherReceivables	0	usd
CY2023Q2	PRSI	Contract Assets Other Than Trade And Other Receivables ContractAssetsOtherThanTradeAndOtherReceivables	1000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	290000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	158000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1061000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	493000	usd
CY2023Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	98684000	usd
CY2023Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	64369000	usd
CY2023Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34315000	usd
CY2023Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	97929000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	63548000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	34381000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	821000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	627000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11093000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	-9600000	usd
CY2023Q3	PRSI	Segment Operating Income Loss SegmentOperatingIncomeLoss	1493000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1606000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	821000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-123000	usd
CY2022Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-100000	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-88000	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	90000	usd
CY2023Q3	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-88000	usd
CY2022Q3	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-10000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4149000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2295000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	2853000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1560000	usd
CY2023Q3	us-gaap	Assets Assets	42771000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12310000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9615000	usd
CY2022Q3	PRSI	Segment Operating Income Loss SegmentOperatingIncomeLoss	2695000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1632000	usd
CY2022Q3	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	627000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-18000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-9000	usd
CY2022Q3	us-gaap	Assets Assets	50125000	usd
CY2023Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1500000	usd
CY2017Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2017Q1	PRSI	Key Money Incentive Advance To Related Party KeyMoneyIncentiveAdvanceToRelatedParty	2000000	usd
CY2017Q1	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P8Y
CY2017Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05275	pure
CY2017Q1	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	Beginning in February 2017, the loan began to amortize over a thirty-year period through its maturity date of January 2024.
CY2023Q3	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	86802000	usd
CY2023Q2	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	87240000	usd
CY2023Q3	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The mezzanine loan is secured by the Operating membership interest held by Mezzanine and is subordinated to the Mortgage Loan. The mezzanine interest only loan had an interest rate of 9.75% per annum and a maturity date of January 1, 2024.
CY2023Q3	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	3682000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	2815000	usd
CY2023Q3	PRSI	Advance Deposits AdvanceDeposits	448000	usd
CY2023Q2	PRSI	Advance Deposits AdvanceDeposits	301000	usd
CY2023Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	571000	usd
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	59000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3155000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	2863000	usd
CY2023Q3	PRSI	Mortgage Interest Payable MortgageInterestPayable	382000	usd
CY2023Q3	PRSI	Withholding And Other Taxes Payable WithholdingAndOtherTaxesPayable	1495000	usd
CY2023Q2	PRSI	Withholding And Other Taxes Payable WithholdingAndOtherTaxesPayable	1204000	usd
CY2023Q3	us-gaap	Security Deposit Liability SecurityDepositLiability	52000	usd
CY2023Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	52000	usd
CY2023Q3	PRSI	Franchise Fee Payable FranchiseFeePayable	1707000	usd
CY2023Q2	PRSI	Franchise Fee Payable FranchiseFeePayable	2510000	usd
CY2023Q3	us-gaap	Management Fee Payable ManagementFeePayable	1106000	usd
CY2023Q2	us-gaap	Management Fee Payable ManagementFeePayable	1683000	usd
CY2023Q3	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	252000	usd
CY2023Q2	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	194000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	12850000	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	11681000	usd

Files In Submission

Name	View Source	Status
0001493152-23-041164-index-headers.html	Edgar Link	pending
0001493152-23-041164-index.html	Edgar Link	pending
0001493152-23-041164.txt	Edgar Link	pending
0001493152-23-041164-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prsi-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
prsi-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
prsi-20230930_cal.xml	Edgar Link	unprocessable
prsi-20230930_lab.xml	Edgar Link	unprocessable
prsi-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRSI
PORTSMOUTH SQUARE INC Stock $prsi

2023 Q4 Form 10-Q Financial Statement

#000149315223041164 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSI PORTSMOUTH SQUARE INC Stock $prsi

2023 Q4 Form 10-Q Financial Statement

#000149315223041164 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSI
PORTSMOUTH SQUARE INC Stock $prsi